Clinical Trial Update: A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer [Phase 3]

View source ↗

Summary

Phase 3 clinical trial sponsored by BioNTech SE evaluating an unnamed investigational therapy for endometrial cancer, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Drugs mentioned

• Investigational therapy (name undisclosed)

Snippet

Sponsor: BioNTech SE | Conditions: Endometrial Cancer | Phase 3 | Status: RECRUITING